By Dan Primack
August 22, 2013

MicuRx Pharmaceuticals Inc., a Hayward, Calif.-based developer of antibiotics to combat infections due to resistant bacteria, has raised $25 million in Series B funding. BVCF led the round, and was joined by return backers Morningside Group and Devon Park Bioventures.

Infraredx Inc.
, a Burlington, Mass.-based developer of medical devices for the diagnosis and management of coronary artery disease, has raised $25 million in equity funding from existing strategic partner Nipro Corp. (Tokyo: 8086). The company previously raised more than $150 million from investors like Sanderling Ventures., a UK-based platform that lets customers sponsor independent winemakers in exchange for discounts, has raised $10 million in third-round funding from Germany’s WIV Wein International

TissueTech Inc., a Doral, Fla.-based regenerative tissue engineering company, has raised $10 million in VC funding from Ballast Point Ventures and River Cities Capital

TagMan, a New York City-based provider of tag management and marketing data solutuions, manages online data, has raised $5 million in third-round funding. Return backers were Greycroft Partners andiNovia Capital were joined by Silicon Valley Bank.

, a developer of online grammar courses and tracking solutions, has raised $2 million in VC funding. Backers include Charles River Ventures, Google Ventures, Learn Capital and Social+Capital Partnership.

Taggo, a Singapore-based marketing platform that turns merchant Facebook pages into loyalty clubs, has raised an undisclosed amount of Series A funding from Jungle Ventures and Spring Seed

Sign up for Dan’s daily email newsletter on deals and deal-makers:

You May Like